Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
about
Targeting the CCL2-CCR2 signaling axis in cancer metastasisMultiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice.Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 productionOral administration of blueberry inhibits angiogenic tumor growth and enhances survival of mice with endothelial cell neoplasmNox-4-dependent nuclear H2O2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formationDissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.Plasma monocyte chemotactic protein-1 remains elevated after minimally invasive colorectal cancer resection.Predictive value of preoperative serum CCL2, CCL18, and VEGF for the patients with gastric cancerIdentification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.Early inflammatory response in epithelial ovarian tumor cyst fluids.Serum monocyte chemoattractant protein-1 in pancreatic cancer.Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.Magnetically-actuated, bead-enhanced silicon photonic immunosensor.Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platformPlasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia.Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course.Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivoA large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.Role of Monocyte Count and Neutrophil-to-Lymphocyte Ratio in Survival of Oral Cancer Patients.The role of macrophages in bone metastasis.A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation.Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients With Stage I Non-Small Cell Lung Cancer Undergoing Complete Resection.Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysisHypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways.Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance.Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma.Protein Mimetic and Anticancer Properties of Monocyte-Targeting Peptide Amphiphile Micelles.MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling
P2860
Q26765184-F335D4B8-E8AA-4E42-9F46-D4D76E39AC5BQ33803085-77D08696-ED8B-41E2-AAA6-645ACA3F3D94Q33980750-4C8C8864-641E-4757-8F44-1FACD7CBE66CQ33986185-7BFE925A-B030-41D7-83DD-B51F0E164471Q34103146-4DB91D01-78F9-4CD2-9A9D-065481B3E533Q34110134-5A7E058A-CE84-41C7-A59C-A95053453CBAQ34141587-1A65F213-7F71-4332-AFBF-AFBDF30DDC29Q34326476-2BB9BA1E-9D06-4261-B7C1-4C1986EA4881Q34340961-EC74A13B-14FD-4658-9913-D9D9E074CD04Q34734529-C42FB518-B593-47A7-812D-9BB1DD943E26Q34851700-EF1EC558-BF71-40B1-9F76-B1E7F8A5ABBCQ34998539-0BE3B783-0561-4611-B186-4CD55DF898C9Q35251086-BCBAAE35-3F28-487D-9B92-A0A82F38AAACQ36121167-1E456AAA-E146-4262-9B65-8CE2240AA18CQ36233334-8FC350DF-ABB7-4549-A6A0-1076D2387849Q36471307-C72EF356-3BBA-439B-84C6-B46B32737DF0Q36667012-AEFFEB21-DFB8-4615-BE83-14F2058D3540Q36821077-44014AF1-B03E-42A2-8FC3-4DC66D75A661Q37109532-C33F641A-B537-4B22-ADD0-A6F7BF88AC45Q37416557-D353B3EE-0B92-4209-A5BD-3FBEF8CC4CF5Q37548729-60ABB177-00E8-4ED6-AF2F-DF86B470F8CEQ38747921-7D32B3E7-FA60-4A9A-AB2A-BC6F7F00D6B1Q40551657-2023258F-FA09-4B93-90DE-917E340D7D87Q40608467-96097855-D895-480B-9AEF-EC5E3CC67791Q41853357-6ED2DF33-3F64-45C1-B41E-2F9420871D47Q42239711-6841106C-D9D5-4F17-ADF3-A931F0CCA16FQ43501864-E0C3904D-A002-439F-972E-16E7A91FF344Q43747287-F26CCAB4-7A7D-4D8C-A5CD-6400CDF1A5F5Q47147736-2A6686F6-7572-4B9F-94EC-C5B001C0CD6BQ54351063-349E87ED-29F3-4293-B1F6-976E32F8D751Q58325237-4D05AA27-979D-46E1-8D71-A56A80D0AD5C
P2860
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
@ast
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
@en
type
label
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
@ast
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
@en
prefLabel
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
@ast
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
@en
P2093
P2860
P356
P1476
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
@en
P2093
Breitenecker G
Leodolter S
Mayerhofer K
Reinthaller A
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690776
P407
P577
1999-11-01T00:00:00Z